Molecular Imaging / 2021 / Article / Tab 1 / Review Article
Comparison of Amino Acid PET to Advanced and Emerging MRI Techniques for Neurooncology Imaging: A Systematic Review of the Recent Studies Table 1 Summary of aaPET with DWI studies.
Study Year Study location No. of patients aaPET DWI Tumor type Main results Castello et al. [48 ] 2020 Rozzano, Italy 124 MET ADC Operated gliomas MET PET is more sensitive for differentiating tumor grade. Both reach comparable accuracy. Popp et al. [47 ] 2019 Freiburg, Germany 41 FET ADC Recurrent GBM FET PET tumor volume is larger than T1w-MRI, which is larger than DWI. DWI volume only partially overlaps with FET PET and T1w-MRI, and correlated poorly with recurrence. Lundemann et al. [49 ] 2019 Copenhagen, Denmark 16 FET EPI Pretreatment GBM Combined parameters could map the probability of recurrence and FET PET more predictive. Werner et al. [50 ] 2019 Cologne, Germany 48 FET ADC Pretreated high-grade glioma FET PET is superior for differentiating tumor progression. Combination yielded highest accuracy. Lohmeier et al. [51 ] 2019 Berlin, Germany 42 FET ADC Glioma Both reliably differentiate recurrence from posttreatment changes, but combined provides best diagnostic accuracy. Verburg et al. [52 ] 2020 Amsterdam, Netherlands 20 FET ADC Newly diagnosed glioma Combination of FET PET with DWI ADC detects infiltration best in enhancing glioma, and DWI ADC with T1w-MRI is best in nonenhancing. Piccardo et al. [54 ] 2019 Genoa, Italy 22 FDOPA ADC Pediatric DMG Both could differentiate tumor grade, but only FDOPA PET could differentiate H3K27M-mutant status independently of histology. Tatekawa et al. [53 ] 2020 Los Angeles, USA 63 FDOPA ADC Treatment-naïve glioma Negatively correlated in IDH-wt and IDH-mutant-1p/19q-non-codeleted. Positively correlated in IDH-mutant-codeleted. John et al. [17 ] 2019 Detroit, USA 30 AMT ADC Newly diagnosed GBM Moderate correlation between AMT uptake and ADC values in nonenhancing tumor regions. Only AMT PET was associated with overall survival and recurrence.